217 related articles for article (PubMed ID: 12408284)
1. Current perspective in insulin therapy in the management of diabetes mellitus.
Garg MK
J Indian Med Assoc; 2002 Mar; 100(3):194-5, 202. PubMed ID: 12408284
[TBL] [Abstract][Full Text] [Related]
2. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
Snyder RW; Berns JS
Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
[TBL] [Abstract][Full Text] [Related]
3. Insulin therapy in type 2 diabetes.
Davis T; Edelman SV
Med Clin North Am; 2004 Jul; 88(4):865-95, x. PubMed ID: 15308383
[TBL] [Abstract][Full Text] [Related]
4. Oral antidiabetic agents: 2004.
Lebovitz HE
Med Clin North Am; 2004 Jul; 88(4):847-63, ix-x. PubMed ID: 15308382
[TBL] [Abstract][Full Text] [Related]
5. New technologies and therapies in the management of diabetes.
Triplitt CL
Am J Manag Care; 2007 Apr; 13 Suppl 2():S47-54. PubMed ID: 17417933
[TBL] [Abstract][Full Text] [Related]
6. In-hospital management of type 2 diabetes mellitus.
Lien LF; Angelyn Bethel M; Feinglos MN
Med Clin North Am; 2004 Jul; 88(4):1085-105, xii. PubMed ID: 15308391
[TBL] [Abstract][Full Text] [Related]
7. Rational choice of oral antihyperglycaemic agents.
Chowdhury S; Sengupta N
J Indian Med Assoc; 2002 Mar; 100(3):174-5, 177. PubMed ID: 12408278
[TBL] [Abstract][Full Text] [Related]
8. [Long-acting insulin analog, glargine, in the treatment of type 1 diabetes].
Tuomi T
Duodecim; 2004; 120(1):88-92. PubMed ID: 14976814
[No Abstract] [Full Text] [Related]
9. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
Hermansen K; Dornhorst A; Sreenan S
Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
[TBL] [Abstract][Full Text] [Related]
10. Making the transition from oral to insulin therapy.
Riddle MC
Am J Med; 2005 May; 118 Suppl 5A():14S-20S. PubMed ID: 15850549
[TBL] [Abstract][Full Text] [Related]
11. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
12. Diabetes drug update: how 4 new options stack up.
Taylor JR; Campbell KM
J Fam Pract; 2007 Mar; 56(3):207-15. PubMed ID: 17343811
[No Abstract] [Full Text] [Related]
13. Noninjectable methods of insulin administration.
Cernea S; Raz I
Timely Top Med Cardiovasc Dis; 2006 Nov; 10():E29. PubMed ID: 17136235
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of chronic diabetes complications depending on the method of insulin therapy in children and adolescents with type 1 diabetes].
Florys B; Ołdytowska A; Głowińska B; Peczyńska J; Urban M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):31-9. PubMed ID: 15355737
[TBL] [Abstract][Full Text] [Related]
15. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
17. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
[TBL] [Abstract][Full Text] [Related]
18. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
[TBL] [Abstract][Full Text] [Related]
19. Selecting among ADA/EASD tier 1 and tier 2 treatment options.
McGill JB
J Fam Pract; 2009 Sep; 58(9 Suppl Treating):S26-34. PubMed ID: 19744422
[TBL] [Abstract][Full Text] [Related]
20. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.
Ligthelm RJ; Mouritzen U; Lynggaard H; Landin-Olsson M; Fox C; le Devehat C; Romero E; Liebl A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):511-9. PubMed ID: 17115349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
